Pascal Soriot

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Pascal Soriot
Pascal Soriot 2019 (cropped).jpg
Soriot in 2019
Born
Pascal Claude Roland Soriot

(1959-05-23) 23 May 1959 (age 61)[1]
NationalityFrench
EducationÉcole nationale vétérinaire d'Alfort[1]
HEC Paris
OccupationBusinessman
Years active1982–present
TitleCEO, AstraZeneca
Term2012–
SuccessorIncumbent
Children2

Pascal Claude Roland Soriot (born 23 May 1959) is the chief executive officer of the Anglo-Swedish pharmaceutical multinational company AstraZeneca, since October 2012.[2]

In July 2017, it was reported that Soriot would become the next CEO of Israel-based Teva Pharmaceutical Industries, succeeding Erez Vigodman, though this was soon refuted.[3][4][5]

Early life[edit]

Born in France, his father died when Soriot was 20.[6]

He studied veterinary medicine at university (École nationale vétérinaire d'Alfort at Maisons-Alfort in south-east Paris).[1] He later obtained an MBA at HEC Paris.[2]

Career[edit]

Roussel Uclaf[edit]

In April 1986, he joined Roussel Uclaf (formerly France's second largest pharmaceutical company, until bought by Hoechst AG in 1997) as a salesman in Australia.[1][7] In 1996 he became General Manager of Hoechst Marion Roussel in Australia, moving to Tokyo in April 1997.

Aventis[edit]

In 2000 he moved to Aventis in America, becoming chief operating officer of Aventis USA in 2002, which became Sanofi Aventis USA in 2004.

Roche[edit]

He joined Roche in 2006. From April 2009 to 2010 he was chief executive of the Roche subsidiary Genentech. He rejoined Roche Pharma AG in 2010 as chief operating officer.[8]

AstraZeneca[edit]

In August 2012 he was named as the new chief executive of AstraZeneca,[9] the world's fifth largest pharmaceutical company, when aged 53. He took up the post on 1 October 2012.

In September 2018 he made headlines commenting on his pay of £9.4m in salary and bonuses,"The truth is I’m the lowest-paid CEO in the whole industry", he said. "It is annoying to some extent. But at the end of the day it is what it is".[10]

Personal life[edit]

He is married and has two children.[11] He has three brothers, all of whom are doctors.[6]

References[edit]

  1. ^ a b c d "Pascal Soriot: Leader of the great escape". Financial Times. Retrieved 26 January 2017.
  2. ^ a b c "Executive Profile: Pascal Soriot". Bloomberg. Retrieved 3 April 2015.
  3. ^ Boland, Hannah (14 July 2017). "Pascal Soriot looks set to stay as AstraZeneca chief". The Telegraph – via www.telegraph.co.uk.
  4. ^ Reuters Editorial (14 May 2014). "AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report". Reuters. Retrieved 12 July 2017.
  5. ^ "Israeli newspaper reports that AstraZeneca CEO Pascal Soriot has agreed to take the helm at Teva – ENDPOINTS NEWS". Endpts.com. Retrieved 12 July 2017.
  6. ^ a b Ralph, Alex (17 May 2019). "A drugs giant that loves to blind rivals with science". The Times. ISSN 0140-0460. Retrieved 17 May 2019.
  7. ^ "Pascal Soriot". Roche.com. Retrieved 26 January 2017.
  8. ^ "AstraZeneca Names Roche's Pascal Soriot as CEO". Bloomberg. Retrieved 6 February 2013.
  9. ^ Rowley, Emma (28 August 2012). "AstraZeneca appoints Roche's Pascal Soriot as new chief". The Telegraph. Retrieved 26 January 2017.
  10. ^ Meddings, Sabah. "Salary size matters, says Astra Zeneca boss on £9.4m" – via www.thetimes.co.uk.
  11. ^ James Ashton (16 May 2014). "Astrazeneca chief Pascal Soriot: I can carry on curing the company, says scientist in £63bn bid battle". Standard.co.uk. Retrieved 26 January 2017.

External links[edit]

Business positions
Preceded by
David Brennan
Chief Executive of AstraZeneca
2012 –
Succeeded by
Incumbent
Preceded by
Chief Operating Officer of Hoffmann-La Roche
2010 – 2012
Succeeded by
Daniel O'Day
Preceded by
Chief Executive of Genentech
2009 – 2010
Succeeded by
Ian Clark